News

This partnership gives sponsors a compelling, high-quality alternative in a space that’s overdue for innovation....

MERIT's ARVO poster reports strong agreement between manual and semi‑automated OCT approaches for identifying incomplete retinal pigment epithelium and outer retinal atrophy (iRORA), a high‑risk precursor to geographic atrophy in age‑related macular degeneration (AMD)....

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="grid" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index=""][vc_column][vc_column_text css=".vc_custom_1774553326813{padding-bottom: 15px !important;}"]March 30, 2026 - MERIT CRO, Inc., a global leader in clinical trial endpoint services and technology, today announced the successful completion of its recent U.S. Food and Drug Administration (FDA) inspection, with the...

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="grid" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index=""][vc_column][vc_column_text css=".vc_custom_1772554514449{padding-bottom: 15px !important;}"]March 3, 2026 - MERIT CRO, Inc., a leading global provider of clinical trial endpoint and technology services, today announced the launch of its newest wholly owned subsidiary, MERIT CRO AUSTRALIA, PTY LTD. The...

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="grid" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index=""][vc_column][vc_column_text css=".vc_custom_1758555649350{padding-bottom: 15px !important;}"]September 22, 2025 - MERIT CRO, Inc., a global leader in clinical trial endpoint services and technology, celebrated the opening of a new, larger office in Shanghai, China. MERIT’s China team has grown rapidly...

MERIT CRO, Inc., a global leader in clinical trial endpoint services and technology, has once again been recognized on the prestigious Inc. 5000 list of fastest-growing private companies in America....

ORC™ represents a potential step forward for clinical endpoints in Dry AMD. We’re proud to offer ORC™ as a novel way of measuring disease progression that may support new and existing treatments for this condition....

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="grid" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index=""][vc_column][vc_column_text css=".vc_custom_1739314400340{padding-bottom: 15px !important;}"]Madison, WI, February 11, 2025 – MERIT, a leading global provider of clinical trial endpoint and technology services, is proud to announce the establishment of its new wholly owned subsidiary, MERIT CRO CANADA (MERIT CANADA)....

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="grid" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index=""][vc_column][vc_column_text css=".vc_custom_1737562928470{padding-bottom: 15px !important;}"]Madison, WI, January 22, 2025 – MERIT, a global clinical trial endpoint and technology services provider, announced today its acquisition of Madison-based OSOD, LLC. This strategic acquisition enhances MERIT's service offerings, enabling a seamless...

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="grid" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index=""][vc_column][vc_column_text]MERIT CRO, Inc., a global endpoint service and technology provider, announced the appointment today of David P. Bingaman, DVM, PhD, D. ACVO as Chief Development Officer (CDO), Ophthalmology. Dr. Bingaman will work with MERIT’s senior management team...

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="grid" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index=""][vc_column][vc_column_text]MERIT CRO, Inc., a global endpoint service and technology provider, today named Heather Baumhauer, MS, as its Chief Operating Officer (COO). Previously, Ms. Baumhauer served as MERIT’s Senior Vice President, Clinical Services. As MERIT’s COO, Ms. Baumhauer...

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="grid" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index=""][vc_column][vc_column_text]MERIT CRO, Inc., a global endpoint service and technology provider specializing in multiple therapeutic areas, announced today that it has been named to the Inc. 5000 list of fastest-growing private companies for the seventh year in a...